Cargando…

Human ELISA Detects anti-SARS-CoV-2 Antibodies in Cats: Seroprevalence and Risk Factors for Virus Spread in Domestic and Stray Cats in Bulgaria

SIMPLE SUMMARY: The aim of the study was to verify whether the human DR-ELISA for the detection of antibodies against the agent of COVID-19 can be applied in cats, as well as to assess the risk factors that determine the spread of the virus among the cat population in Bulgaria. Therefore, 92 serum s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sirakov, Ivo, Rusenova, Nikolina, Rusenov, Anton, Gergova, Raina, Strateva, Tanya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861929/
https://www.ncbi.nlm.nih.gov/pubmed/36669043
http://dx.doi.org/10.3390/vetsci10010042
_version_ 1784874964678082560
author Sirakov, Ivo
Rusenova, Nikolina
Rusenov, Anton
Gergova, Raina
Strateva, Tanya
author_facet Sirakov, Ivo
Rusenova, Nikolina
Rusenov, Anton
Gergova, Raina
Strateva, Tanya
author_sort Sirakov, Ivo
collection PubMed
description SIMPLE SUMMARY: The aim of the study was to verify whether the human DR-ELISA for the detection of antibodies against the agent of COVID-19 can be applied in cats, as well as to assess the risk factors that determine the spread of the virus among the cat population in Bulgaria. Therefore, 92 serum samples collected from 68 domestic and 24 stray cats were analyzed and compared with a multi-species ELISA kit. The results showed 83.33% positive results in stray cats and 41.18% in domestic cats, respectively, by both assays. Cats under 7 years had a five times higher risk than those over 7 years. The risk was seven times higher for stray cats than for domestic cats. Additionally, the results indicate the highest risk for cats in villages. This study demonstrates that human DR-ELISA may be helpful in monitoring the circulation of the virus in cats. ABSTRACT: The aim of this study was to verify whether the human DR-ELISA for the detection of anti-SARS-CoV-2 antibodies can be applied in cats, and to assess the risk factors that determine the spread of the virus among the cat population in Bulgaria. The study included 92 serum samples collected from 68 domestic and 24 stray cats aged from 3 months to 20 years of age in the period of January–June 2021. The samples originated from three regions in Bulgaria and from three places of inhabitance. DR-ELISA based on peroxidase-labeled SARS-CoV-2 N protein was employed to detect IgA, IgG and IgM antibodies in the samples. Subsequently, the results were compared with a commercially available multi-species ELISA kit. There was high seroprevalence (83.33%) in stray cats and 41.18% in domestic cats, confirmed by the human and veterinary ELISA kit. The positive cases in the regional cities were 42.86%, in small towns 50% and in villages 78.26%. Cats under 7 years had a five times higher risk than those over 7 years (p = 0.001). The risk was seven times higher for stray cats than for domestic cats (p = 0.001). In addition, the results indicate that the risk was the highest for cats in villages (p = 0.006) compared to cats in other places of inhabitance. This study demonstrates that human DR-ELISA may be successfully applied to monitor the circulation of SARS-CoV-2 in cats and other susceptible species. Cats might serve as sentinel animals for tracking the virus in nature and in inhabited areas (strays) and to discover asymptomatic cases in humans/owners.
format Online
Article
Text
id pubmed-9861929
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98619292023-01-22 Human ELISA Detects anti-SARS-CoV-2 Antibodies in Cats: Seroprevalence and Risk Factors for Virus Spread in Domestic and Stray Cats in Bulgaria Sirakov, Ivo Rusenova, Nikolina Rusenov, Anton Gergova, Raina Strateva, Tanya Vet Sci Article SIMPLE SUMMARY: The aim of the study was to verify whether the human DR-ELISA for the detection of antibodies against the agent of COVID-19 can be applied in cats, as well as to assess the risk factors that determine the spread of the virus among the cat population in Bulgaria. Therefore, 92 serum samples collected from 68 domestic and 24 stray cats were analyzed and compared with a multi-species ELISA kit. The results showed 83.33% positive results in stray cats and 41.18% in domestic cats, respectively, by both assays. Cats under 7 years had a five times higher risk than those over 7 years. The risk was seven times higher for stray cats than for domestic cats. Additionally, the results indicate the highest risk for cats in villages. This study demonstrates that human DR-ELISA may be helpful in monitoring the circulation of the virus in cats. ABSTRACT: The aim of this study was to verify whether the human DR-ELISA for the detection of anti-SARS-CoV-2 antibodies can be applied in cats, and to assess the risk factors that determine the spread of the virus among the cat population in Bulgaria. The study included 92 serum samples collected from 68 domestic and 24 stray cats aged from 3 months to 20 years of age in the period of January–June 2021. The samples originated from three regions in Bulgaria and from three places of inhabitance. DR-ELISA based on peroxidase-labeled SARS-CoV-2 N protein was employed to detect IgA, IgG and IgM antibodies in the samples. Subsequently, the results were compared with a commercially available multi-species ELISA kit. There was high seroprevalence (83.33%) in stray cats and 41.18% in domestic cats, confirmed by the human and veterinary ELISA kit. The positive cases in the regional cities were 42.86%, in small towns 50% and in villages 78.26%. Cats under 7 years had a five times higher risk than those over 7 years (p = 0.001). The risk was seven times higher for stray cats than for domestic cats (p = 0.001). In addition, the results indicate that the risk was the highest for cats in villages (p = 0.006) compared to cats in other places of inhabitance. This study demonstrates that human DR-ELISA may be successfully applied to monitor the circulation of SARS-CoV-2 in cats and other susceptible species. Cats might serve as sentinel animals for tracking the virus in nature and in inhabited areas (strays) and to discover asymptomatic cases in humans/owners. MDPI 2023-01-06 /pmc/articles/PMC9861929/ /pubmed/36669043 http://dx.doi.org/10.3390/vetsci10010042 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sirakov, Ivo
Rusenova, Nikolina
Rusenov, Anton
Gergova, Raina
Strateva, Tanya
Human ELISA Detects anti-SARS-CoV-2 Antibodies in Cats: Seroprevalence and Risk Factors for Virus Spread in Domestic and Stray Cats in Bulgaria
title Human ELISA Detects anti-SARS-CoV-2 Antibodies in Cats: Seroprevalence and Risk Factors for Virus Spread in Domestic and Stray Cats in Bulgaria
title_full Human ELISA Detects anti-SARS-CoV-2 Antibodies in Cats: Seroprevalence and Risk Factors for Virus Spread in Domestic and Stray Cats in Bulgaria
title_fullStr Human ELISA Detects anti-SARS-CoV-2 Antibodies in Cats: Seroprevalence and Risk Factors for Virus Spread in Domestic and Stray Cats in Bulgaria
title_full_unstemmed Human ELISA Detects anti-SARS-CoV-2 Antibodies in Cats: Seroprevalence and Risk Factors for Virus Spread in Domestic and Stray Cats in Bulgaria
title_short Human ELISA Detects anti-SARS-CoV-2 Antibodies in Cats: Seroprevalence and Risk Factors for Virus Spread in Domestic and Stray Cats in Bulgaria
title_sort human elisa detects anti-sars-cov-2 antibodies in cats: seroprevalence and risk factors for virus spread in domestic and stray cats in bulgaria
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861929/
https://www.ncbi.nlm.nih.gov/pubmed/36669043
http://dx.doi.org/10.3390/vetsci10010042
work_keys_str_mv AT sirakovivo humanelisadetectsantisarscov2antibodiesincatsseroprevalenceandriskfactorsforvirusspreadindomesticandstraycatsinbulgaria
AT rusenovanikolina humanelisadetectsantisarscov2antibodiesincatsseroprevalenceandriskfactorsforvirusspreadindomesticandstraycatsinbulgaria
AT rusenovanton humanelisadetectsantisarscov2antibodiesincatsseroprevalenceandriskfactorsforvirusspreadindomesticandstraycatsinbulgaria
AT gergovaraina humanelisadetectsantisarscov2antibodiesincatsseroprevalenceandriskfactorsforvirusspreadindomesticandstraycatsinbulgaria
AT stratevatanya humanelisadetectsantisarscov2antibodiesincatsseroprevalenceandriskfactorsforvirusspreadindomesticandstraycatsinbulgaria